As we reported recently in our blog, Stryker has agreed to pay more than $1 billion to settle lawsuits relating to its recalled hip implants. The settlement is expected to pay a base amount of

Following the conclusion of a trial that began on February 3 in the U.S. District Court for the Western District of Louisiana, a U.S. jury ordered Takeda and Eli Lilly to pay a combined $9 billion in punitive

A lawsuit alleging personal injuries after implantation of a Stryker hip that was filed in California Superior Court, has been moved to U.S. District Court, Eastern District of California. According to her lawsuit, Mary Hazelwood alleges that the hip

As we have reported previously in our blog, our firm has been involved in Stryker litigation, including lawsuits over defective hip implants manufactured by the company. Recently, Reuters reported Stryker has been ordered to pay the U.S. government $80 million

According to the Economic Times, Sun Pharmaceuticals Ltd. is recalling 200 vials of the chemotherapy drug gemcitabine in the United States due to a lack of assurance of sterility. The U.S. Food and Drug Administration (FDA) announced

According to the Cleveland Plain Dealer, a supplier of a store brand Tylenol is recalling 18 batches of its infant suspension liquid because some packages may contain syringes without dose markings, making inaccurate dosing and overdose

According to Pscyhcentral.com, a review done by researchers suggests that antidepressant medications like SSRIs including Prozac, Zoloft, Paxil, Lexapro, Luvox and Celexa, can increase the risk of preterm birth. “Preterm birth is a major clinical problem throughout

Recently, Fortune reported that a study showed that people with lower back pain were no better off taking Tylenol than taking a placebo—this is alarming as “chronic pain effects about 100 million adults and cost the United

Public Citizen, a patient advocate group, proposes that since Congress passed legislation to accelerate the approval process for drugs they are more likely to be given safety warnings or pulled from the market. According to Public

Specialty Compounding, LLC, a subsidiary of Peoples Pharmacy Inc., issued a voluntary recall of all lots of defective sterile medications within expiry. The recall came after reports of bacterial infection affecting 15 patients at two Texas hospitals,